Maravai LifeSciences (MRVI) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Guggenheim Initiates Coverage on Maravai Lifesciences With Neutral Rating
MT Newswires07:36 ET
Express News | Maravai LifeSciences Holdings Inc - Co's Unit Pre-Paid $228 Million of Term Loan
Reuters16:36 ET
Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating
Moomoo NewsDec 6 09:33 ET · Ratings
Craig-Hallum Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI)
TipRanksDec 6 08:56 ET · Ratings
Maravai Lifesciences Chairman Carl Hull to Retire, R. Andrew Eckert to Succeed
TipRanksDec 5 16:31 ET
Maravai LifeSciences Appoints R. Andrew Eckert as New Chairman of the Board Following Carl Hull's Retirement
Quiver QuantitativeDec 5 16:13 ET

Comments

Stock_Drift

Sep 24 07:16

$Maravai LifeSciences (MRVI.US)$

Moomoo AI

Apr 6 09:07

Despite Maravai LifeSciences Holdings' significant liabilities, it has net cash, indicating a light debt load. However, its pre-interest and tax loss and declining revenue raise future earnings and balance sheet health concerns.

Is Maravai LifeSciences Holdings (NASDAQ:MRVI) Using Debt In A Risky Way?

1

Moomoo AI

Dec 21, 2023 06:11

While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

Moomoo AI

Dec 21, 2023 06:02

While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

Moomoo AI

Dec 21, 2023 05:43

While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

MRVI Maravai LifeSciences

Trade Overview

Capital Trend

News

Comments